	1 2 3 4 5 6 7 8 9
Journal of Controlled Release	Journal of Controlled Release, 9, 5.56% Journal of Controlled Release 9 publications, 5.56%
Journal of Drug Targeting	Journal of Drug Targeting, 5, 3.09% Journal of Drug Targeting 5 publications, 3.09%
Journal of Liposome Research	Journal of Liposome Research, 5, 3.09% Journal of Liposome Research 5 publications, 3.09%
Tumori	Tumori, 4, 2.47% Tumori 4 publications, 2.47%
International Journal of Pharmaceutics	International Journal of Pharmaceutics, 4, 2.47% International Journal of Pharmaceutics 4 publications, 2.47%
Expert Opinion on Drug Delivery	Expert Opinion on Drug Delivery, 4, 2.47% Expert Opinion on Drug Delivery 4 publications, 2.47%
Biochimica et Biophysica Acta - Biomembranes	Biochimica et Biophysica Acta - Biomembranes, 3, 1.85% Biochimica et Biophysica Acta - Biomembranes 3 publications, 1.85%
Colloids and Surfaces B: Biointerfaces	Colloids and Surfaces B: Biointerfaces, 3, 1.85% Colloids and Surfaces B: Biointerfaces 3 publications, 1.85%
Chemistry - A European Journal	Chemistry - A European Journal, 2, 1.23% Chemistry - A European Journal 2 publications, 1.23%
Breast	Breast, 2, 1.23% Breast 2 publications, 1.23%
Nanomedicine	Nanomedicine, 2, 1.23% Nanomedicine 2 publications, 1.23%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 2, 1.23% International Journal of Molecular Sciences 2 publications, 1.23%
Pharmaceutics	Pharmaceutics, 2, 1.23% Pharmaceutics 2 publications, 1.23%
Drug Safety	Drug Safety, 2, 1.23% Drug Safety 2 publications, 1.23%
Journal of Pharmaceutical Sciences	Journal of Pharmaceutical Sciences, 2, 1.23% Journal of Pharmaceutical Sciences 2 publications, 1.23%
Nanomedicine: Nanotechnology, Biology, and Medicine	Nanomedicine: Nanotechnology, Biology, and Medicine, 2, 1.23% Nanomedicine: Nanotechnology, Biology, and Medicine 2 publications, 1.23%
Biomedicine and Pharmacotherapy	Biomedicine and Pharmacotherapy, 2, 1.23% Biomedicine and Pharmacotherapy 2 publications, 1.23%
Advanced Drug Delivery Reviews	Advanced Drug Delivery Reviews, 2, 1.23% Advanced Drug Delivery Reviews 2 publications, 1.23%
Photochemistry and Photobiology	Photochemistry and Photobiology, 2, 1.23% Photochemistry and Photobiology 2 publications, 1.23%
Journal of Physical Chemistry B	Journal of Physical Chemistry B, 2, 1.23% Journal of Physical Chemistry B 2 publications, 1.23%
New Journal of Chemistry	New Journal of Chemistry, 2, 1.23% New Journal of Chemistry 2 publications, 1.23%
Materials	Materials, 1, 0.62% Materials 1 publication, 0.62%
Cancer Treatment Reviews	Cancer Treatment Reviews, 1, 0.62% Cancer Treatment Reviews 1 publication, 0.62%
Applied Physics Letters	Applied Physics Letters, 1, 0.62% Applied Physics Letters 1 publication, 0.62%
Journal of Pharmacology and Experimental Therapeutics	Journal of Pharmacology and Experimental Therapeutics, 1, 0.62% Journal of Pharmacology and Experimental Therapeutics 1 publication, 0.62%
Current Cancer Therapy Reviews	Current Cancer Therapy Reviews, 1, 0.62% Current Cancer Therapy Reviews 1 publication, 0.62%
Vaccine	Vaccine, 1, 0.62% Vaccine 1 publication, 0.62%
Seminars in Oncology	Seminars in Oncology, 1, 0.62% Seminars in Oncology 1 publication, 0.62%
Future Cardiology	Future Cardiology, 1, 0.62% Future Cardiology 1 publication, 0.62%
	1 2 3 4 5 6 7 8 9

Publishers

	10 20 30 40 50 60
Elsevier	Elsevier, 52, 32.1% Elsevier 52 publications, 32.1%
Taylor & Francis	Taylor & Francis, 23, 14.2% Taylor & Francis 23 publications, 14.2%
Wiley	Wiley, 15, 9.26% Wiley 15 publications, 9.26%
Springer Nature	Springer Nature, 15, 9.26% Springer Nature 15 publications, 9.26%
American Chemical Society (ACS)	American Chemical Society (ACS), 10, 6.17% American Chemical Society (ACS) 10 publications, 6.17%
MDPI	MDPI, 8, 4.94% MDPI 8 publications, 4.94%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 6, 3.7% Royal Society of Chemistry (RSC) 6 publications, 3.7%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 4, 2.47% Ovid Technologies (Wolters Kluwer Health) 4 publications, 2.47%
SAGE	SAGE, 4, 2.47% SAGE 4 publications, 2.47%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 3, 1.85% Bentham Science Publishers Ltd. 3 publications, 1.85%
Mary Ann Liebert	Mary Ann Liebert, 2, 1.23% Mary Ann Liebert 2 publications, 1.23%
Pharmaceutical Society of Japan	Pharmaceutical Society of Japan, 2, 1.23% Pharmaceutical Society of Japan 2 publications, 1.23%
Frontiers Media S.A.	Frontiers Media S.A., 2, 1.23% Frontiers Media S.A. 2 publications, 1.23%
Oxford University Press	Oxford University Press, 2, 1.23% Oxford University Press 2 publications, 1.23%
AIP Publishing	AIP Publishing, 1, 0.62% AIP Publishing 1 publication, 0.62%
American Society for Pharmacology and Experimental Therapeutics	American Society for Pharmacology and Experimental Therapeutics, 1, 0.62% American Society for Pharmacology and Experimental Therapeutics 1 publication, 0.62%
Impact Journals	Impact Journals, 1, 0.62% Impact Journals 1 publication, 0.62%
S. Karger AG	S. Karger AG, 1, 0.62% S. Karger AG 1 publication, 0.62%
Spandidos Publications	Spandidos Publications, 1, 0.62% Spandidos Publications 1 publication, 0.62%
OOO Zhurnal "Mendeleevskie Soobshcheniya"	OOO Zhurnal "Mendeleevskie Soobshcheniya", 1, 0.62% OOO Zhurnal "Mendeleevskie Soobshcheniya" 1 publication, 0.62%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 1, 0.62% Public Library of Science (PLoS) 1 publication, 0.62%
Begell House	Begell House, 1, 0.62% Begell House 1 publication, 0.62%
American Society for Microbiology	American Society for Microbiology, 1, 0.62% American Society for Microbiology 1 publication, 0.62%
American Association for Cancer Research (AACR)	American Association for Cancer Research (AACR), 1, 0.62% American Association for Cancer Research (AACR) 1 publication, 0.62%
American Society of Clinical Oncology (ASCO)	American Society of Clinical Oncology (ASCO), 1, 0.62% American Society of Clinical Oncology (ASCO) 1 publication, 0.62%
IntechOpen	IntechOpen, 1, 0.62% IntechOpen 1 publication, 0.62%
	10 20 30 40 50 60

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

162

Cite this

GOST |

Cite this

GOST Copy

Tardi P., Boman N., Cullis P. Liposomal Doxorubicin // Journal of Drug Targeting. 1996. Vol. 4. No. 3. pp. 129-140.

GOST all authors (up to 50) Copy

Tardi P., Boman N., Cullis P. Liposomal Doxorubicin // Journal of Drug Targeting. 1996. Vol. 4. No. 3. pp. 129-140.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.3109/10611869609015970

UR - http://www.tandfonline.com/doi/full/10.3109/10611869609015970

TI - Liposomal Doxorubicin

T2 - Journal of Drug Targeting

AU - Tardi, Paul

AU - Boman, Nancy

AU - Cullis, Peter

PY - 1996

DA - 1996/01/01

PB - Taylor & Francis

SP - 129-140

IS - 3

VL - 4

PMID - 8959485

SN - 1061-186X

SN - 1029-2330

SN - 1026-7158

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{1996_Tardi,

author = {Paul Tardi and Nancy Boman and Peter Cullis},

title = {Liposomal Doxorubicin},

journal = {Journal of Drug Targeting},

year = {1996},

volume = {4},

publisher = {Taylor & Francis},

month = {jan},

url = {http://www.tandfonline.com/doi/full/10.3109/10611869609015970},

number = {3},

pages = {129--140},

doi = {10.3109/10611869609015970}

}

MLA

Cite this

MLA Copy

Tardi, Paul, et al. “Liposomal Doxorubicin.” Journal of Drug Targeting, vol. 4, no. 3, Jan. 1996, pp. 129-140. http://www.tandfonline.com/doi/full/10.3109/10611869609015970.

Publisher

Taylor & Francis

Journal

Journal of Drug Targeting

scimago Q1

wos Q1

SJR

0.870

CiteScore

8.9

Impact factor

3.9

ISSN

1061186X (Print)

10292330 (Electronic)

10267158